Howard S Hochster
Dr. Howard Hochster is an internationally known expert in Cancer Clinical Trials and early cancer drug development, particularly in gastrointestinal cancer. He joined the Yale faculty in July, 2010, as Associate Cancer Center Director for Clinical Research and Director of GI Oncology. He has published widely on treatment of colon, pancreatic and gastric cancer and has been in the forefront of developing newer chemotherapy and targeted agents for these diseases. Dr. Hochster directed the Office of Clinical Trials and Developmental Therapeutics at the NYU Cancer Institute during his tenure there (1987-2010) among several other leadership positions. He was President of the New York Cancer Society in 2004 through 2006 and is a Medical Director of the Chemotherapy Foundation, as well as advisor to the Israel Cancer Research Foundation. He has served on several NIH study sections and ASCO committee. In 2009-2010 he chaired the colorectal track for the ASCO Annual meeting.
Colorectal Neoplasms; Esophageal Neoplasms; Gastrointestinal Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms